Table 2 Comparison of baseline characteristics between patients with T2DM with and without MACE
Characteristics | Total (n = 265) | MACE (-) (n = 214) | MACE (+) (n = 51) | P value |
|---|---|---|---|---|
CACS | 35.70 (0.00-225.70) | 30.46 (0.00-185.70) | 112.01 (0.76-428.89) | 0.102 |
0 | 77(29.06) | 64(29.91) | 13(25.49) | Â |
1–99 | 98(36.98) | 89(41.59) | 9(17.65) |  |
100–399 | 38(14.34) | 23(10.75) | 15(29.41) |  |
400–1000 | 26(9.81) | 19(8.88) | 7(13.73) |  |
> 1000 | 26(9.81) | 19(8.88) | 7(13.73) | 0.001* |
CACS (≥ 100) | 90(33.96) | 61(28.50) | 29(56.86) | < 0.001* |
Stenosis degree | ||||
0% | 36 (13.58) | 32(14.95) | 4(7.84) | Â |
1-24% | 34(12.83) | 30(14.02) | 4(7.84) | Â |
25-49% | 109(41.13) | 93(43.46) | 16(31.37) | Â |
50-69% | 42(15.85) | 25(11.68) | 17(33.33) | Â |
70-100% | 44(16.60) | 34(15.89) | 10(19.61) | 0.002* |
Obstructive stenosis | 55(20.75) | 37(17.29) | 18(35.29) | 0.004* |
MVD | 37(13.96) | 28(13.08) | 9(17.65) | 0.398 |
Treatment-early revascularization | 30(11.32) | 29(13.55) | 1(1.96) | 0.019* |
Total plaque burden (%) | 1.62 (0.57–3.78) | 1.43 (0.54–3.54) | 2.05 (0.80–4.77) | 0.083 |
High-attenuation plaque burden proportion (%) | 49.72 (0.00-75.97) | 41.39 (0.00-75.19) | 62.48 (4.20-80.38) | 0.146 |
Medium-attenuation plaque burden proportion (%) | 20.63 (5.68-50.00) | 23.47 (7.11–51.85) | 11.81 (3.49–41.09) | 0.032* |
Low-attenuation plaque burden proportion (%) | 24.39 (12.06–42.72) | 24.97 (12.06–42.07) | 22.52 (12.08–42.93) | 0.807 |
HRP | 21(7.92) | 13(6.07) | 8(15.69) | 0.046* |
HPR features | ||||
Positive remodeling | 13(4.91) | 8(3.74) | 5(9.80) | 0.149 |
Low-attenuation plaque | 12(4.53) | 9(4.21) | 3(5.88) | 0.886 |
Napkin-ring sign | 6(2.26) | 4(1.87) | 2(3.92) | 0.718 |
Spotty calcification | 18(6.79) | 10(4.67) | 8(15.69) | 0.012 |